We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIXM icon
13551
PUT
ProShares VIX Mid-Term Futures ETF
VIXM
$94.3M
$4.09K ﹤0.01%
200
-2,000
-91% -$50K
UAVS icon
13552
AgEagle Aerial Systems
UAVS
$63.9M
$4.09K ﹤0.01%
18
-2
-10% -$715
SNPE icon
13553
CALL
Xtrackers S&P 500 ESG ETF
SNPE
$2.79B
$4.06K ﹤0.01%
100
-900
-90% -$34.5K
FCUV icon
13554
PUT
Focus Universal
FCUV
$3.95M
$4.05K ﹤0.01%
7
-5
-42% -$3.51K
TELA icon
13555
PUT
TELA Bio
TELA
$28.9M
$4.05K ﹤0.01%
400
-1,300
-76% -$13.3K
CTOS icon
13556
PUT
Custom Truck One Source
CTOS
$2.4B
$4.04K ﹤0.01%
600
CEI
13557
PUT
DELISTED
Camber Energy, Inc
CEI
$4.02K ﹤0.01%
6,300
-1,400
-18% -$1.67K
LOGC
13558
DELISTED
ContextLogic
LOGC
$3.99K ﹤0.01%
606
-472,803
-100% -$3.75M
OXSQ icon
13559
CALL
Oxford Square Capital
OXSQ
$157M
$3.98K ﹤0.01%
1,500
+800
+114% +$2.34K
DZSI
13560
CALL
DELISTED
DZS Inc. Common Stock
DZSI
$3.97K ﹤0.01%
1,000
-17,300
-95% -$101K
HOOK
13561
PUT
DELISTED
HOOKIPA Pharma
HOOK
$3.96K ﹤0.01%
450
+400
+800% +$4.44K
VIRX
13562
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.95K ﹤0.01%
2,800
+2,200
+367% +$3.15K
ALPP
13563
CALL
DELISTED
Alpine 4 Holdings Inc
ALPP
$3.92K ﹤0.01%
1,941
-697
-26% -$1.85K
FORA
13564
PUT
DELISTED
Forian
FORA
$3.92K ﹤0.01%
1,600
-400
-20% -$1.07K
ZINGW
13565
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
$3.9K ﹤0.01%
251,762
-2,356
-0.9% -$46
NGNE icon
13566
CALL
Neurogene
NGNE
$723M
$3.9K ﹤0.01%
235
-455
-66% -$7.46K
PCY icon
13567
PUT
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
$3.9K ﹤0.01%
200
-100
-33% -$1.91K
PRPH
13568
DELISTED
ProPhase Labs
PRPH
$3.88K ﹤0.01%
54
-2,431
-98% -$198K
RDWR icon
13569
CALL
Radware
RDWR
$1.23B
$3.88K ﹤0.01%
200
-29,600
-99% -$592K
BLFS icon
13570
BioLife Solutions
BLFS
$1.72B
$3.87K ﹤0.01%
175
-31,339
-99% -$660K
EWQ icon
13571
CALL
iShares MSCI France ETF
EWQ
$332M
$3.85K ﹤0.01%
100
-24,500
-100% -$941K
TRUE
13572
CALL
DELISTED
TrueCar
TRUE
$3.84K ﹤0.01%
1,700
-2,600
-60% -$6.19K
ANIX icon
13573
PUT
Anixa Biosciences
ANIX
$108M
$3.84K ﹤0.01%
1,200
-6,200
-84% -$23.9K
ETON icon
13574
PUT
Eton Pharmaceutcials
ETON
$1.61B
$3.84K ﹤0.01%
1,100
+1,000
+1,000% +$3.68K
SACH
13575
CALL
Sachem Capital Corp
SACH
$37.9M
$3.84K ﹤0.01%
1,100
-2,200
-67% -$7.43K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.